---  
layout: startup_page  
title: "Glycomine"  
id: "glycomine.com"  
permalink: "/glycomineglycomine.com04162025/"  
website: "http://www.glycomine.com/"  
funding_round: "Series C"  
funding_amount: "$115M"  
investors: "CTI Life Sciences Fund, funds managed by abrdn Inc., Advent Life Sciences, Novo Holdings, Sanofi Ventures, Abingworth, RiverVest Venture Partners, Sanderling Ventures, Chiesi Ventures, Remiges Ventures, Asahi Kasei Ventures"  
about: "Glycomine is a clinical-stage biotechnology company developing treatments for rare diseases lacking therapeutic options. Its lead candidate, GLM101, is a mannose-1-phosphate replacement therapy for PMM2-CDG, a life-threatening genetic disorder. The therapy aims to restore pathway function by bypassing disease-causing mutations."  
markets: "Biotechnology, Pharmaceuticals, Rare Diseases"  
hq: "San Francisco, California, United States"  
founded_year: "2015"  
linkedin: "https://www.linkedin.com/company/glycomine-inc-"  
twitter: "https://twitter.com/GlycomineBio"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/glycomine"  
pitchbook: "https://pitchbook.com/profiles/company/123277-69"  

date_display: "16-Apr-2025"  
date: "2025-04-16"

# SEO Optimization  
meta_title: "Glycomine - Series C Funding ($115M)"  
meta_description: "Glycomine, Glycomine is a clinical-stage biotechnology company developing treatments for rare diseases lacking therapeutic options. Its lead candidate, GLM101, i..."  
meta_keywords: "Glycomine, Biotechnology, Pharmaceuticals, Rare Diseases, Series C funding"  
canonical_url: "https://startup.projectstartups.com/glycomineglycomine.com04162025/"  
---